PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF 14 LEUKEMIA AND LYMPHOMA CELL-LINES WITH 11Q23 TRANSLOCATIONS

被引:21
作者
IIDA, S
SAITO, M
OKAZAKI, T
SETO, M
YAMAMOTO, K
AKAO, Y
OGURA, M
SUZUKI, H
ARIYOSHI, Y
KOIKE, K
NITTA, M
TAKAHASHI, T
UEDA, R
NAKAZAWA, S
机构
[1] AICHI CANC CTR, RES INST, CHEMOTHERAPY LAB, CHIKUSA KU, NAGOYA, AICHI 464, JAPAN
[2] AICHI CANC CTR, DEPT HEMATOL & CHEMOTHERAPY, NAGOYA, AICHI 464, JAPAN
[3] AICHI CANC CTR, IMMUNOL LAB, NAGOYA, AICHI 464, JAPAN
[4] AICHI CANC CTR, DEPT CLIN LABS, NAGOYA, AICHI 464, JAPAN
[5] KEIO UNIV, SCH MED, DEPT PEDIAT, TOKYO 108, JAPAN
[6] SOCIAL INSURANCE SAITAMA CENT HOSP, IMMUNOL RES LAB, SAITAMA, JAPAN
[7] NAGOYA CITY UNIV, SCH MED, DEPT INTERNAL MED 2, NAGOYA, AICHI 467, JAPAN
[8] YAMANASHI UNIV, COLL MED, DEPT PEDIAT, KOFU, YAMANASHI 400, JAPAN
关键词
11Q23; TRANSLOCATION; CELL LINE; T(4,11)(Q21,Q23); T(11,19)(Q23,P13); PHENOTYPE; GENOTYPE;
D O I
10.1016/0145-2126(92)90113-L
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11q23 translocation is the most popular chromosomal abnormality in infant leukemia. In adults, it is often encountered in non-Hodgkin's lymphoma (NHL). In this study, we analyzed the phenotypic and genotypic characteristics of 9 acute leukemic cell lines with 11q23 translocations and one with deletion of the 11q23 locus, nine of which were established by researchers in this group, together with 4 NHL cell lines with 11q23 translocations. All lines were considered to belong to the B-cell lineage at different stages. All 10 leukemic lines showed clonal rearrangement of the immunoglobulin heavy chain (IgH) gene: two corresponded to the B-precursor stage (CD19+, cytoplasmic mu-), while the other 8 corresponded to the pre-B stage (cytoplasmic mu+). All 4 NHL lines showed rearrangements of both the IgH and Igkappa genes with three expressing surface Ig; specifically, mature B-cell phenotype. As for myelocytic-monocytic markers, at least one out of 4 antigens examined were positive in 8 of the 10 leukemic cell lines, while only one of the 4 NHL lines was reactive. There were essentially no clear phenotypic or genotypic differences between t(4;11) and t(11;19) cell lines, supporting the view that both diseases-have similar clinicopathological characteristics. These cell lines are also valuable for cloning genes at the chromosomal breakpoints.
引用
收藏
页码:1155 / 1163
页数:9
相关论文
共 36 条
[1]   SIGNIFICANCE OF ABNORMALITIES INVOLVING CHROMOSOMAL SEGMENT 11Q22-25 IN ACUTE-LEUKEMIA [J].
ABE, R ;
SANDBERG, AA .
CANCER GENETICS AND CYTOGENETICS, 1984, 13 (02) :121-127
[2]  
AKAO Y, 1991, CANCER RES, V51, P6708
[3]  
AKAO Y, 1991, CANCER RES, V51, P1574
[4]  
BLOOMFIELD CD, 1983, CANCER RES, V43, P868
[5]  
CIMINO G, 1991, CANCER RES, V51, P6712
[6]  
COTTER FE, 1991, CYTOGENET CELL GENET, V58, P1957
[7]  
CRIST WM, 1985, BLOOD, V66, P33
[8]   CLONING, EXPRESSION AND LOCALIZATION OF AN RNA HELICASE GENE FROM A HUMAN LYMPHOID-CELL LINE WITH CHROMOSOMAL BREAKPOINT 11Q23.3 [J].
DAN, L ;
YUNIS, JJ .
NUCLEIC ACIDS RESEARCH, 1992, 20 (08) :1967-1972
[9]  
DYER MJS, 1990, BLOOD, V75, P709
[10]   INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA WITH T(11-19) [J].
GIBBONS, B ;
KATZ, FE ;
GANLY, P ;
CHESSELLS, JM .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) :264-269